Caricamento...
3,4-Methylenedioxymethamphetamine (Ecstasy) Inhibits Dyskinesia Expression and Normalizes Motor Activity in 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Treated Primates
Ecstasy [3,4-methylenedioxymethamphetamine (MDMA)] was shown to prolong the action of l-3,4-dihydroxyphenylalanine (l-DOPA) while suppressing dyskinesia in a single patient with Parkinson's disease (PD). The clinical basis of this effect of MDMA is unknown but may relate to its actions on eithe...
Salvato in:
| Pubblicato in: | J Neurosci |
|---|---|
| Autori principali: | , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Society for Neuroscience
2003
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6740822/ https://ncbi.nlm.nih.gov/pubmed/14534244 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1523/JNEUROSCI.23-27-09107.2003 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|